Attached files
| file | filename |
|---|---|
| EX-32.01 - EXHIBIT 32.01 - Tonix Pharmaceuticals Holding Corp. | v432316_ex32-01.htm |
| EX-21.01 - EXHIBIT 21.01 - Tonix Pharmaceuticals Holding Corp. | v432316_ex21-01.htm |
| EX-31.01 - EXHIBIT 31.01 - Tonix Pharmaceuticals Holding Corp. | v432316_ex31-01.htm |
| EX-31.02 - EXHIBIT 31.02 - Tonix Pharmaceuticals Holding Corp. | v432316_ex31-02.htm |
| 10-K - FORM 10-K - Tonix Pharmaceuticals Holding Corp. | v432316_10k.htm |
Exhibit 23.01
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements [Form S-3 No. 333-192541 and Form S-8 No. 333-202006] of Tonix Pharmaceuticals Holding Corp. of our report dated March 3, 2016, with respect to the consolidated financial statements of Tonix Pharmaceuticals Holding Corp. and our report dated March 3, 2016 with respect to the effectiveness of Tonix Pharmaceutical Holding Corp.'s internal control over financial reporting included in this Annual Report on Form 10-K for the year ended December 31, 2015.
| /s/ EisnerAmper LLP | |
| New York, New York | |
| March 3, 2016 |